Automated and Closed Cell Therapy Market Size & Share, By Workflow (Separation, Expansion, Apheresis, Fill – Finish, Cryopreservation, Others), Type (Stem Cell Therapy, Non- Stem Cell Therapy), Scale (Pre-commercial/R&D Scale, Commercial scale) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 7126| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Automated and Closed Cell Therapy Market size is expected to see substantial growth, increasing from USD 1.51 billion in 2024 to USD 11.68 billion by 2034, at a CAGR of over 22.7%. By 2025, the industry revenue is estimated to be USD 1.82 billion.

Base Year Value (2024)
USD 1.51 billion
CAGR (2025-2034)
22.7%
Forecast Year Value (2034)
USD 11.68 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Automated and Closed Cell Therapy Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: One of the primary growth drivers for the Automated and Closed Cell Therapy Market is the increasing demand for personalized medicine. As advancements in genetic research enable more tailored therapeutic approaches, healthcare providers are increasingly focusing on developing personalized therapies that cater to individual patient needs. Automated systems provide the precision and efficiency required to deliver tailored treatments, thereby enhancing patient outcomes. This growing trend towards personalized medicine is expected to propel the market forward as more healthcare institutions adopt automated closed-cell therapies. Another significant growth driver is the rising prevalence of chronic diseases, including cancer and autoimmune disorders. With chronic conditions becoming more common due to lifestyle changes and an aging population, there is an urgent need for innovative treatment solutions that can improve patient care. Automated and closed cell therapies offer an effective means to deliver targeted treatments, potentially reducing side effects and improving recovery times. This increasing disease burden is driving investment and research into advanced therapeutic options, further boosting market growth. The advancements in technology and automation in the healthcare sector significantly contribute to the growth of the Automated and Closed Cell Therapy Market. Modern automation solutions enhance the efficiency of cell processing and handling, reducing the likelihood of human error, and speeding up the production of therapies. These technological innovations not only improve the quality and consistency of cell therapies but also reduce operational costs, making it more feasible for healthcare providers to implement closed-cell therapy solutions. The ongoing development of more sophisticated automation technologies will likely continue to be a catalyst for market expansion. Industry Restraints: Despite the positive growth outlook, one of the major restraints in the Automated and Closed Cell Therapy Market is the high cost of implementation. The adoption of automated systems and closed cell therapies often involves significant financial investment in terms of equipment, training, and infrastructure. Many healthcare facilities, especially in emerging markets, struggle with budget constraints, limiting their ability to invest in these advanced treatment solutions. This economic barrier can slow the penetration of automated therapies in certain regions, hindering overall market growth. Another notable restraint is the regulatory challenges associated with cell therapies. The complexity of developing and validating new automated and closed cell therapy treatments requires rigorous regulatory approval processes. These processes can be time-consuming and costly, leading to delays in bringing new therapies to market. Additionally, stringent regulations vary across different regions, which can complicate the process for manufacturers seeking to expand their market presence. These regulatory hurdles can deter investment and innovation in the automated closed-cell therapy sector, posing a challenge to its growth trajectory.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Automated and Closed Cell Therapy Market
Largest Region
North America
46% Market Share in 2024
North America The Automated and Closed Cell Therapy Market in North America is primarily driven by the presence of advanced healthcare infrastructure, a high prevalence of chronic diseases, and a significant focus on research and development in biotechnology and pharmaceuticals. The U.S. dominates this region with a robust number of ongoing clinical trials and a strong pipeline of innovative therapies. Key players in the market are heavily investing in automation technologies to enhance the efficiency of cell therapy processes. Canada is also emerging as a critical player, focusing on regulatory support and collaboration between academia and industry to advance cell therapies. Asia Pacific The Asia Pacific region is witnessing rapid growth in the Automated and Closed Cell Therapy Market, fueled by increasing investments in healthcare infrastructure and rising awareness of advanced therapeutic options. China is leading the market due to a growing number of biotech companies and significant government initiatives aimed at encouraging innovation in the life sciences sector. Japan contributes with its emphasis on regenerative medicine and advanced cell therapies, while South Korea is emerging as a hub for research and commercialization of cell therapies, supported by strong academic research and a favorable regulatory environment. Europe In Europe, the Automated and Closed Cell Therapy Market is characterized by an increasing focus on regenerative medicine and a favorable regulatory framework that encourages innovation. The United Kingdom is at the forefront, driven by a robust biotech sector and numerous initiatives aimed at accelerating cell therapy research and development. Germany is a significant contributor to the market, with advanced manufacturing capabilities and a strong emphasis on quality standards. France is also expanding its presence in the market, supported by public and private investments in life sciences, leading to advancements in cell therapy approaches and technologies.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Workflow The Automated and Closed Cell Therapy Market is segmented by workflow into Separation, Expansion, Apheresis, Fill-Finish, Cryopreservation, and Others. The Separation segment leads the market, driven by advancements in technology and increasing demand for high-purity cell isolates essential for therapeutic applications. Expansion follow closely, propelled by the rising need for cell proliferation in therapies, particularly in stem cell applications. Apheresis, an essential procedure for collecting blood components, is also significant in this market, with increasing adoption due to its efficiency in obtaining specific cell types. The Fill-Finish segment is witnessing growth, supported by the need for proper packaging and storage of cell therapy products to ensure their efficacy and safety. Cryopreservation plays a vital role in long-term storage of cells, further driving its demand. Other workflows, while smaller segments, contribute through niche applications and emerging technologies, enhancing overall market diversity. Type The market is categorized into two types: Stem Cell Therapy and Non-Stem Cell Therapy. Stem Cell Therapy dominates the market segment, buoyed by its innovative potential for treating various chronic diseases, genetic disorders, and regenerative medicine. The growing number of clinical trials and research activities focusing on stem cells significantly contribute to its growth. Non-Stem Cell Therapy, while comparatively smaller, is gaining traction due to advancements in cellular therapies such as CAR-T and other immune-based treatments. The diversity in treatment applications across both types fosters a dynamic market environment where competition drives innovation and enhances treatment options for patients. Scale The Automated and Closed Cell Therapy Market is further divided by scale into Pre-commercial/R&D Scale and Commercial Scale. The Pre-commercial/R&D Scale segment is crucial for developing and refining new therapies, often supported by research institutions and biopharmaceutical companies. This segment is characterized by a high rate of innovation and experimentation, as organizations seek to validate new treatment methodologies and expedite pathways to commercialization. The Commercial Scale segment, however, holds the larger share of the market, attributed to the increasing approval and marketing of cell therapies that can meet large-scale patient needs. This segment benefits from established infrastructure and regulatory frameworks, enabling efficient production and distribution of cell therapy products. The interplay between both scales highlights the ongoing transition from research to real-world applications, underscoring the market’s evolution.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The competitive landscape in the Automated and Closed Cell Therapy Market is characterized by a dynamic array of established pharmaceutical companies, biotechnological firms, and innovative startups that are continually striving to enhance their technologies and therapeutic offerings. The market is witnessing significant investments in research and development, focusing on improving the efficiency and effectiveness of cell therapies. Companies are forging strategic partnerships and collaborations to leverage synergies in technology and expertise, enabling them to accelerate the product development process. The rise in personalized medicine and regenerative therapies is further intensifying competition, as firms race to acquire and develop novel cell therapy solutions that meet regulatory standards and cater to diverse patient needs. Top Market Players 1. Novartis 2. Gilead Sciences 3. Bristol-Myers Squibb 4. Kite Pharma 5. bluebird bio 6. Celgene (acquired by Bristol-Myers Squibb) 7. Spark Therapeutics 8. Celyad 9. Takeda Pharmaceutical Company 10. Amgen
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Automated and Closed Cell Therapy Market — Custom Segments

Segment Sub-Segment
No segment data available.

Automated and Closed Cell Therapy Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →